Cardiotoxicity Induced by Cancer Treatment

Cancer and cardiac disease are the two most common causes of death. As cancersurvivorship rises, understanding of the links between cancer treatments and cardiovasculardisorders becomes essential for all medical physicians. As cure rates improve, increasing prioritycan be given to optimising quality of life rather than focusing on prevention of cancer recurrence.Patients may view the adverse effects of cancer treatment in equal concern with the diagnosis ofcancer itself, and with the development of new anti-cancer therapies, physicians should be cautiousfor the symptoms and signs of emerging cardiovascular complications.The last decade has seen an exponential growing in the numbers of anti cancer treatments available,specially systemic anti cancer treatment and also radiotherapy. It is these two anti cancer treatmentsthat are implicated in the emerging field of cardio-oncology, whether the aim of cancer treatment iscurative or palliative.This lecture explores the relationship of these managements and cardiotoxicity, signsand symptoms; biomarkers, the imaging modalities for assessments and the managementoptions available